Skip to main content
Clinical Trials/ISRCTN16442558
ISRCTN16442558
Completed
未知

Evaluation of the clinical efficacy and safety of Perindopril / Indapamide / Amlodipine fixed-dose combination in single-pill versus free dual therapy at the same dose as the single-pill combination in patients with uncontrolled essential hypertension

Institut de Recherches Internationales Servier (France)0 sites150 target enrollmentOctober 19, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Essential hypertension
Sponsor
Institut de Recherches Internationales Servier (France)
Enrollment
150
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
October 19, 2012
End Date
September 1, 2014
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institut de Recherches Internationales Servier (France)

Eligibility Criteria

Inclusion Criteria

  • 1\. Men or women of any ethnic origin \> or \= 18 years old
  • 2\. Uncontrolled hypertension

Exclusion Criteria

  • 1\. Pregnancy, breastfeeding or possibility of becoming pregnant during the study
  • 2\. Hypertension known to be resistant to diuretics or ACE inhibitors
  • 3\. Secondary hypertension
  • 4\. Complicated hypertension
  • 5\. Obesity
  • 6\. History of renal disease, ventricular rhythm disorders, atrial fibrillation, atrial flutter
  • 7\. Diabetes
  • 8\. Grapefruit juice is forbidden during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials